Adualys Therapeutics AG

History from 18 Nov 2025

Nominal capital · CHFCHF 126k

SHAB published 21 Nov 2025 · legal date 18 Nov 2025
Company formed
Founded 18 Nov 2025
SHAB HR01-1006491260 ↗
SHAB published 21 Nov 2025 · legal date 18 Nov 2025
Capital band adopted
SHAB HR01-1006491260 ↗
SHAB published 8 Apr 2026 · legal date 30 Mar 2026
Capital increase
Likely financing
Paid in cash
Nominal capital
100’000 → 125’811.78
Shares
10’000’000 → 12’581’178
New shares, % of post-step shares
20.5% (2’581’178 new)
Aktienkapital neu: CHF 125'811.78 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 125'811.78 [bisher: CHF 100'000.00]. Aktien neu: 12'581'178 Namenaktien zu CHF 0.01 [bisher: 10'000'000 Namenaktien zu CHF 0.01]. [gestrichen: Kapitalband gemäss näherer Umschreibung in den Statuten.]
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
- The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
- The company was founded less than six years before this capital increase.+0.5
- The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability
SHAB HR02-1006618644 ↗
SHAB published 8 Apr 2026 · legal date 30 Mar 2026
Capital band adopted
SHAB HR02-1006618644 ↗

Published by 12 Apr 2026

Record